Indeed, blood vessels of TNFα‐CSG‐treated tumours when labelled by i.v. injection of FITC–lectin were significantly dilated compared to vessels in control CSG‐treated or TNFα‐RGR‐treated tumours (Figs 6A and EV5C). The gene discussed is TNF; the disease is neoplasm.